electroCore, Inc.
NASDAQ: ECORBasking Ridge, US · Delaware corporation · 3 known investors
electroCore develops non-invasive vagus nerve stimulation (nVNS) medical devices, marketed as gammaCore, to treat patients suffering from pain and chronic conditions. The company operates in the bioelectronic medicine field and sells its products in markets including the US, UK, EU countries, Canada, Australia, New Zealand, and Saudi Arabia.
Founders & leadership
JE
JP ErricoFounder
BP
Brian PosnerExecutive
DS
Daniel S. GoldbergerExecutive
PS
Peter StaatsExecutive
FA
Frank AmatoExecutive
Board
TM
Trevor MoodyBoard director
JT
PC
Peter CuneoBoard director
JA
Julie A. GoldsteinBoard director
TM
Thomas M. PattonBoard director
TJ
Thomas J. ErricoBoard director
JP
John P. GandolfoBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$86.8M disclosed across 10 of 16 rounds · 2016–2026
▶Undisclosed amountofferedApr 2026 · Other Health CareRule 506(b)
▶Undisclosed amountofferedApr 2026 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas M. PattonDirector
- John P. GandolfoDirector
- Michael FoxExecutive Officer
- Joshua LevExecutive Officer
- Elena BonfiglioliDirector
- Julie Ann GoldsteinDirector
- Thomas J. ErricoDirector
- Patricia WilberDirector
- James C. TheofilosDirector
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedOct 2025 · 3 investors · Other Health CareRule 506(b)
▶$1.9MraisedOct 2025 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas J. ErricoDirector
- Joshua LevExecutive Officer
- Patricia WilberDirector
- Thomas M. PattonDirector
- Elena BonfiglioliDirector
- James C. TheofilosDirector
- John P. GandolfoDirector
- Daniel S. GoldbergerExecutive Officer, Director
- Julie Ann GoldsteinDirector
- Offering amount
- $1.9M
- Amount sold
- $1.9M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedOct 2025 · Other Health CareRule 506(b)
▶Undisclosed amountofferedOct 2025 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Patricia WilberDirector
- Daniel S. GoldbergerExecutive Officer, Director
- Julie Ann GoldsteinDirector
- Joshua LevExecutive Officer
- Thomas J. ErricoDirector
- Elena BonfiglioliDirector
- James C. TheofilosDirector
- Thomas M. PattonDirector
- John P. GandolfoDirector
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedSep 2025 · Other Health CareRule 506(b)
▶Undisclosed amountofferedSep 2025 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joshua LevExecutive Officer
- Patricia WilberDirector
- John P. GandolfoDirector
- Thomas M. PattonDirector
- Julie Ann GoldsteinDirector
- James C. TheofilosDirector
- Elena BonfiglioliDirector
- Thomas J. ErricoDirector
- Daniel S. GoldbergerExecutive Officer, Director
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedNov 2024 · Other Health CareRule 506(b)
▶Undisclosed amountofferedNov 2024 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas M. PattonDirector
- Peter CuneoDirector
- Charles S. TheofilosDirector
- Daniel S. GoldbergerExecutive Officer, Director
- John P. GandolfoDirector
- Joshua LevExecutive Officer
- Patricia WilberDirector
- Thomas J. ErricoDirector
- Julie A. GoldsteinDirector
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedAug 2024 · Other Health CareRule 506(b)
▶Undisclosed amountofferedAug 2024 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Peter CuneoDirector
- Brian PosnerExecutive Officer
- Julie A. GoldsteinDirector
- Thomas M. PattonDirector
- Daniel S. GoldbergerExecutive Officer, Director
- Thomas J. ErricoDirector
- John P. GandolfoDirector
- Patricia WilberDirector
- Charles S. TheofilosDirector
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.8MraisedJun 2024 · 13 investors · Other Health CareRule 506(b)
▶$7.8MraisedJun 2024 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Patricia WilberDirector
- Julie A. GoldsteinDirector
- Brian PosnerExecutive Officer
- Thomas J. ErricoDirector
- Charles S. TheofilosDirector
- Daniel S. GoldbergerExecutive Officer, Director
- Thomas M. PattonDirector
- Peter CuneoDirector
- John P. GandolfoDirector
- Offering amount
- $7.8M
- Amount sold
- $7.8M
- Finders' fees
- $17.5K
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedMay 2024 · Other Health CareRule 506(b)
▶Undisclosed amountofferedMay 2024 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brian PosnerExecutive Officer
- Peter CuneoDirector
- Daniel S. GoldbergerExecutive Officer, Director
- John P. GandolfoDirector
- Thomas J. ErricoDirector
- Charles S. TheofilosDirector
- Thomas M. PattonDirector
- Julie A. GoldsteinDirector
- Patricia WilberDirector
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapProcore47 shared keywordsAll-in-one construction management software platform
Uclahealth47 shared keywordsUCLA Health is an academic health system providing primary, immediate, and specialty medical care including cancer, neuroscience, transplant, orthopedics, cardiovascular, and children's care. It operates hospitals and clinics and trains medical students, with a network of locations in the Los Angeles area.
Companies competing with electroCore, Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does electroCore, Inc. do?
- electroCore develops non-invasive vagus nerve stimulation (nVNS) medical devices, marketed as gammaCore, to treat patients suffering from pain and chronic conditions. The company operates in the bioelectronic medicine field and sells its products in markets including the US, UK, EU countries, Canada, Australia, New Zealand, and Saudi Arabia.
- Who founded electroCore, Inc.?
- electroCore, Inc. was founded by JP Errico.
- Who are electroCore, Inc.'s investors?
- electroCore, Inc.'s investors include Foothill Ventures, Tullis Health Investors, Tullis.
- How much funding has electroCore, Inc. raised?
- electroCore, Inc. has disclosed $86.8M raised across 10 of its 16 known rounds.
- Where is electroCore, Inc. headquartered?
- electroCore, Inc. is headquartered in Basking Ridge, US.